Literature DB >> 311647

Failure of indomethacin to close persistent ductus arteriosus in infants weighing under 1000 grams.

H H Ivey, J Kattwinkel, T S Park, L J Krovetz.   

Abstract

Six preterm infants with a persistent ductus arteriosus, who failed to improve with conventional medical management, received indomethacin in an attempt to close the duct pharmacologically. All infants weighed less than 1000 g when the drug was administered. All showed a transient response to indomethacin; however, no infant demonstrated a permanent response, even though 5 of the 6 received multiple doses. One of the patients developed a severe episode of anuria, uraemia, and gastrointestinal bleeding. Of the 6 infants, 3 underwent subsequent successful surgical ligation of the ductus. It is suggested that the extremely preterm infant may be a 'poor responder' to indomethacin. Since the side effects of indomethacin may be life-threatening, it may be wise to consider surgical ligation in lieu of indomethacin administration in these infants.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 311647      PMCID: PMC482031          DOI: 10.1136/hrt.41.3.304

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  11 in total

1.  Editorial: Patent ductus revisited.

Authors:  A S Nadas
Journal:  N Engl J Med       Date:  1976-09-02       Impact factor: 91.245

2.  Failure of indomethacin therapy to induce closure of patent ductus arteriosus in premature infants with respiratory distress syndrome.

Authors:  W A Neal; J M Kyle; M D Mullett
Journal:  J Pediatr       Date:  1977-10       Impact factor: 4.406

3.  Incidence and treatment of the patent ductus arteriosus in the ill premature neonate.

Authors:  R D Zachman; G P Steinmetz; R J Botham; S N Graven; M K Ledbetter
Journal:  Am Heart J       Date:  1974-06       Impact factor: 4.749

4.  Commentary: new thoughts on an old problem--patent ductus arteriosus in the premature infant.

Authors:  W F Friedman; M A Heymann; A M Rudolph
Journal:  J Pediatr       Date:  1977-02       Impact factor: 4.406

5.  Prevention of apnea and bradycardia in low-birthweight infants.

Authors:  D C Shannon; F Gotay; I M Stein; M C Rogers; I D Todres; F M Moylan
Journal:  Pediatrics       Date:  1975-05       Impact factor: 7.124

6.  Delayed closure of the ductus arteriosus in premature infants.

Authors:  D Danilowicz; A M Rudolph; J I Hoffman
Journal:  Pediatrics       Date:  1966-01       Impact factor: 7.124

7.  Patent ductus arteriosus complicating the respiratory distress syndrome in preterm infants.

Authors:  D W Thibeault; G C Emmanouilides; R J Nelson; R S Lachman; R M Rosengart; W Oh
Journal:  J Pediatr       Date:  1975-01       Impact factor: 4.406

8.  Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis.

Authors:  M A Heymann; A M Rudolph; N H Silverman
Journal:  N Engl J Med       Date:  1976-09-02       Impact factor: 91.245

9.  Patent ductus arteriosus complicating respiratory distress syndrome.

Authors:  W A Neal; F B Bessinger; C E Hunt; R V Lucas
Journal:  J Pediatr       Date:  1975-01       Impact factor: 4.406

10.  Pharmacologic closure of patent ductus arteriosus in the premature infant.

Authors:  W F Friedman; M J Hirschklau; M P Printz; P T Pitlick; S E Kirkpatrick
Journal:  N Engl J Med       Date:  1976-09-02       Impact factor: 91.245

View more
  15 in total

1.  Patent ductus arteriosus in premature babies.

Authors:  M L Chiswick
Journal:  Br Med J (Clin Res Ed)       Date:  1981-12-05

Review 2.  Analgesic nephropathy: a reassessment of the role of phenacetin and other analgesics.

Authors:  L F Prescott
Journal:  Drugs       Date:  1982 Jan-Feb       Impact factor: 9.546

3.  Indomethacin in closure of patent ductus arteriosus.

Authors:  V V Vedanarayanan; I C Verma
Journal:  Indian J Pediatr       Date:  1981 Jul-Aug       Impact factor: 1.967

Review 4.  The pharmacological treatment of patent ductus arteriosus. A review of the evidence.

Authors:  R J Barst; W M Gersony
Journal:  Drugs       Date:  1989-08       Impact factor: 9.546

Review 5.  A risk-benefit assessment of therapies for premature labour.

Authors:  K Higby; C R Suiter
Journal:  Drug Saf       Date:  1999-07       Impact factor: 5.606

6.  Variation in the diagnosis and management of patent ductus arteriosus in premature infants.

Authors:  L S Lai; B W McCrindle
Journal:  Paediatr Child Health       Date:  1998-11       Impact factor: 2.253

7.  Intravenous indometacin in preterm infants with symptomatic patent ductus arteriosus. A population pharmacokinetic study.

Authors:  J M Smyth; P S Collier; M Darwish; J S Millership; H L Halliday; S Petersen; J C McElnay
Journal:  Br J Clin Pharmacol       Date:  2004-09       Impact factor: 4.335

8.  Patent ductus arteriosus in premature infants: a review of current management.

Authors:  W A Neal; M D Mullett
Journal:  Pediatr Cardiol       Date:  1982       Impact factor: 1.655

9.  Multiple courses of indomethacin and neonatal outcomes in premature infants.

Authors:  Madhavi Sangem; Sumita Asthana; Sanjiv Amin
Journal:  Pediatr Cardiol       Date:  2007-12-18       Impact factor: 1.655

10.  Indomethacin treatment in small versus large premature infants with ductus arteriosus. Comparison of plasma indomethacin concentration and clinical response.

Authors:  T F Yeh; J Luken; D Raval; A Thalji; I Carr; R S Pildes
Journal:  Br Heart J       Date:  1983-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.